Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Standard of Care × NET × 90 days × Clear all

Sponsor

Cancer Type

Gastrointestinal 19 Genitourinary 16 Breast 16 Thoracic 13 Tumor-Agnostic 9 Other hematologic neoplasm 9 Other solid neoplasm 8 Head & Neck 7 Sarcoma 5 Gynecologic 5 Lymphoid 4 Dermatologic 4 CNS 3 Plasma cell 2 Other 2 Myeloid 2 Endocrine 2 Other neoplasm 1

Interventions

lutetium Lu 177 dotatate 13 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Everolimus 7 pembrolizumab 4 cabozantinib 3 X-Rays 3 Octreotide 3 Fluorodeoxyglucose F18 3 pasireotide 2 lenvatinib 2 gallium Ga 68 dotatate 2 Sunitinib 2 Phantoms, Imaging 2 Nivolumab 2 Ipilimumab 2 Etoposide 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 2 tivozanib 1 surufatinib 1 peposertib 1 pazopanib 1 lanreotide 1 guarana powder 1 gadoteridol 1 gadoterate meglumine 1 gadolinium ethoxybenzyl DTPA 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡